Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Laverman, G
STABLE-1, NCT05454709 / 2022-000427-20: A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System	Withdrawn	2	12	Europe	Dasiglucagon, GlucaGen	Inreda Diabetic B.V., Zealand Pharma	Diabetes Mellitus, Type 1	12/23	12/23